// App-Quantinova.ai

2183 : Targeting TRBC1 and 2 for the treatment of T cell lymphomas

Researchers

Presenter

  • Mathieu Ferrari

Principal Investigators

  • Vania Baldan

  • Priyanka Ghongane

  • Alex Nicholson

  • Reyisa Bughda

  • Zulaikha Akbar

  • Patrycja Wawrzyniecka

  • Paul Maciocia

  • Shaun Cordoba

  • Simon Thomas

  • Shimobi Onuoha

  • Martin Pule

Medical Centers

  • Autolus Therapeutics, London, NJ, United Kingdom

  • Kings College London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • T-cell lymphoma

Biomarkers

  • Coxsackie Virus And Adenovirus Receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved